Fairmount Funds Management LLC - 13 Sep 2024 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: Director, 10%+ Owner
Signature: /s/ Tomas Kiselak, Managing Member of Fairmount Funds Management LLC
Issuer symbol: VRDN
Transactions as of: 13 Sep 2024
Net transactions value: +$30,000,000
Form type: 4
Filing time: 17 Sep 2024, 21:00:13 UTC
Previous filing: 17 Sep 2024
Next filing: 01 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRDN	Common Stock	Purchase	$30,000,000	+1,600,000	+87%	$18.75	3,445,813	13 Sep 2024	Fairmount Healthcare Fund II LP	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Remarks:

The Reporting Persons may each be deemed a director by deputization of Issuer by virtue of the fact that each of Peter Harwin and Tomas Kiselak serve on the board of directors of Issuer and are also each a Managing Member of Fairmount Funds Management LLC.